Reference
Unglaub JM, et al. Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study. Blood 138 (Suppl. 1): 4418, 23 Nov 2021. Available from: URL: http://doi.org/10.1182/blood-2021-151287 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1889, 43 (2022). https://doi.org/10.1007/s40278-022-08722-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08722-3